美股異動|受美國副總統萬斯發佈積極評論提振 英特爾續升超3.5%
英特爾(INTC.US)升超3.5%,報21.71美元。該股昨日升超6%。消息面上,美國副總統萬斯表示:“為了保護美國的競爭優勢,特朗普政府將確保最強大的人工智能系統在美國製造,並使用美國設計和製造的芯片。”此前總統特朗普已簽署了行政命令,將減少美國人工智能技術領域的監管障礙並進一步促進行業創新。另外,據報Tom's Hardware對英特爾最新款Arrow Lake架構芯片Core Ultra 9 275HX進行評測,發現在中央處理器跑分測試CPU Mark較AMD Ryzen 9 7945HX3D晶片效能高7%,較英特爾上一代的i9-14900HX效能提升34%。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.